울산의대, 경북의대 / 주지현, 양정덕, 박종무*, 김수산*
Abstract
Background and purpose: The European Society for Radiotherapy and Oncology (ESTRO) recently defined delineation guidelines for the clinical target volume for postmastectomy radiation therapy (PMRT) after immediate implant-based reconstruction for early-stage breast cancer. We analyzed the three-dimensional location and pattern of local recurrence in accordance with the reconstruction type and ESTRO-target volume.
Materials and methods: This retrospective study involved patients who had undergone mastectomy with implant reconstruction between 2010 and 2019 and who had local recurrence as the first event. For mapping analysis, one subpectoral and one prepectoral implant patient were selected. All recurrence lesions were contoured and mapped in a representative case.
Results: A total of 1327 patients with breast cancer who underwent mastectomy and implant-based breast reconstruction were identified; 51 were enrolled with a total of 65 lesions. In subpectoral implant patients, 93% of recurrences were located in the ESTRO-target volume. No recurrence occurred in the implant pocket, but 7% of the recurrent tumors developed in the pectoralis major and deep thoracic muscle. In prepectoral implant patients, all recurrent tumors occurred within the ESTRO-target volume.
Conclusion: The ESTRO-target volume in PMRT after reconstruction encompassed most local recurrences in patients who underwent mastectomy with immediate implant reconstruction. Our results support the application of the ESTRO Advisory Committee for Radiation Oncology Practice consensus guideline for target volume of PMRT after immediate implant-based reconstruction for early-stage breast cancer.
Affiliations
Ji Hyeon Joo 1 , Jung Dug Yang 2 , Ho Yong Park 3 , Jaehyeon Park 4 , Zhen-Yu Wu 5 , BeomSeok Ko 6 , Jongmoo Park 7 , Su Ssan Kim 8
1 Department of Radiation Oncology, Pusan National University Yangsan Hospital, Pusan National University School of Medicine, Yangsan, Republic of Korea.
2 Department of Plastic and Reconstructive Surgery, School of Medicine, Kyungpook National University, Daegu, Republic of Korea.
3 Department of Surgery, School of Medicine, Kyungpook National University, Daegu, Republic of Korea.
4 Department of Radiation Oncology, Yeungnam University College of Medicine, Daegu, Republic of Korea.
5 Department of Breast Surgery, Shanghai East Hospital, Tongji University School of Medicine, China; Division of Breast Surgery, Department of Surgery, University of Ulsan College of Medicine, Asan Medical Center, Seoul, Republic of Korea.
6 Division of Breast Surgery, Department of Surgery, University of Ulsan College of Medicine, Asan Medical Center, Seoul, Republic of Korea.
7 Department of Radiation Oncology, School of Medicine, Kyungpook National University, Daegu, Korea. Electronic address: fauny11@naver.com.
8 Department of Radiation Oncology, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Republic of Korea. Electronic address: watermountain@hanmail.net.
편집위원
유방전절제술 후 implant로 재건을 시행한 유방암 환자에서 국소 재발의 위치를 자세하게 분석하여, ESTRO에서 제시한 표적체적 가이드라인이 적절한지를 평가한 논문
2022-06-23 14:13:51